FilingReader Intelligence
New Industries Biomedical gains EU certification for products
August 20, 2025 at 10:14 AM UTC•By FilingReader AI
Shenzhen New Industries Biomedical Engineering has received IVDR CE certification for 18 of its chemiluminescence immunoassay reagent products from TÜV SÜD, valid until December 14, 2025.
The company now has IVDR CE certifications for 211 chemiluminescence immunoassay reagent products and 67 biochemical reagent products. The certification is required for these products to enter the EU market.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:300832•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Shenzhen New Industries Biomedical Engineering publishes news
Free account required • Unsubscribe anytime